FDA Inspection 1137256 — Julie Shepard MD
The FDA completed an inspection of Julie Shepard MD on March 18, 2021 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 18, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dayton, OH (United States)
Additional Details
Clinical Investigator (CI)